About NEWBURY PHARMACEUTICALS AB
Newbury Pharmaceuticals AB is a hybrid pharmaceutical company, which engages in specialty prescription drugs inn the Scandinavian markets. The company was founded by Karl Karlsson in 2020 and is headquartered in Lund, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange NEWBURY PHARMACEUTICALS stocks are traded under the ticker P52.
Yes, you can track NEWBURY PHARMACEUTICALS financials in yearly and quarterly reports right on TradingView.
No, P52 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, P52 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade NEWBURY PHARMACEUTICALS stock right from TradingView charts — choose your broker and connect to your account.
We've gathered analysts' opinions on NEWBURY PHARMACEUTICALS future price: according to them, P52 price has a max estimate of 0.69 EUR and a min estimate of 0.69 EUR. Read a more detailed NEWBURY PHARMACEUTICALS forecast: see what analysts think of NEWBURY PHARMACEUTICALS and suggest that you do with its stocks.